Global Lung Cancer Therapeutics Market 2015-2019

Logo

Naperville, IL -- (SBWire) -- 12/10/2014 --Reportstack, provider of premium market research reports announces the addition of Global Lung Cancer Therapeutics Market 2015-2019 market report to its offering

About Lung Cancer

Cancer occurs when, after undergoing cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Non-small cell lung cancer is the commonest type of lung cancer and forms almost 85-90 percent of the total cases diagnosed. It grows and spreads slowly. Smoking is considered as a major cause of lung cancer, though lung cancer also occurs in non-smokers. Non-small cell lung cancer is of three types: squamous cell (epidermoid) carcinoma, adenocarcinoma, and large cell (undifferentiated) carcinoma. Small cell lung cancers form roughly 10-15 percent of all the diagnosed cases of lung cancer. There are two types of small cell lung cancer: small cell carcinoma and combined small cell carcinoma. It can be classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer cannot be cured using current therapies available in the market. Some of the common symptoms associated with lung cancer are chest pain, persistent cough, blood in sputum, fatigue, loss of appetite, weight loss, shortness of breath, and wheezing. Both small cell lung cancer and non-small cell lung cancer are recurrent in nature, which are difficult to cure.

Analysts forecast the Global Lung Cancer Therapeutics market to grow at a CAGR of 3.83 percent over the period 2014-2019.

Covered in this Report:

This report covers the present scenario and the growth prospects of the Global Lung Cancer Therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of non-small cell lung cancer and small cell lung cancer.

The Global Lung Cancer Therapeutics market is segmented based on the type of molecule used for the treatment of lung cancer, which include:

Biologics
Small molecules

In addition, the market is also segmented based on the route of administration followed for the treatment of lung cancer, which include:

Oral
Parenteral

Global Lung Cancer Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Lung Cancer Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions:

Americas
APAC
EMEA

Key Vendors:

AstraZeneca
Celgene
Eli Lilly
F. Hoffmann-La Roche
Pfizer

Other Prominent Vendors:

Abbvie
Aetna
Agennix
Amgen
Boehringer Ingelheim
Celldex
Eisai
GlaxoSmithKline
GTx
Helsinn
IMClone
Merck Serono
Novartis
Qiagen
OncoGenex
OSI Pharmaceuticals
Peregrine
Pierre Fabre
Sanofi
Synta
Telik
Teva Pharmaceutical

Market Driver:

High Unmet Need
For a full, detailed list, view our report

Market Challenge:

High Cost of Therapy
For a full, detailed list, view our report

Market Trend:

Personalized Medicine
For a full, detailed list, view our report

Key Questions Answered in this Report:

What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Companies Mentioned:

AstraZeneca, Celgene, Eli Lilly, F. Hoffmann-La Roche, Pfizer, Abbvie, Aetna, Agennix , Amgen, Boehringer Ingelheim, Celldex, Eisai, GlaxoSmithKline, GTx, Helsinn, IMClone, Merck Serono, Novartis, Qiagen, OncoGenex, OSI Pharmaceuticals, Peregrine,Pierre Fabre, Sanofi, Synta, Telik, Teva Pharmaceutical

Complete report is available
http://www.reportstack.com/product/187059/global-lung-cancer-therapeutics-market-2015-2019.html

Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604

Media Relations Contact

Salil Modak
Director of Marketing
http://www.reportstack.com

View this press release online at: http://rwire.com/567748